LAVA Therapeutics News

LAVA Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

May 21 16:10 ET

LAVA Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 21 07:06 ET

LAVA Therapeutics | 20-F: Registration statement / Annual report / Transition report

Mar 20 16:09 ET

LAVA Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novo Holdings A/S(0%)

Mar 7 19:11 ET

LAVA Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(7.9%),Jeremy C. Green(7.9%), etc.

Feb 14 16:29 ET

LAVA Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 16, 2023 16:05 ET

LAVA Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novo Holdings A/S(7.1%)

Nov 9, 2023 16:37 ET

LAVA Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 22, 2023 16:05 ET

LAVA Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 15, 2023 06:30 ET

LAVA Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jun 15, 2023 16:50 ET

LAVA Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Jun 8, 2023 16:05 ET

LAVA Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novo Holdings A/S(9.13%)

Jun 5, 2023 20:18 ET

LAVA Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 5, 2023 18:30 ET

LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Apr 24, 2023 16:05 ET

LAVA Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 12, 2023 06:01 ET

LAVA Therapeutics: FY2022 Annual Report

20-F | LAVA Therapeutics NV (0001840748) (Filer)

Apr 11, 2023 16:23 ET

LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Mar 13, 2023 07:02 ET

LAVA Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novo Holdings A/S(11.7%)

Feb 24, 2023 16:38 ET

LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Feb 16, 2023 07:04 ET

LAVA Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Feb 6, 2023 07:06 ET